HK1014137A1 - Benzopyrans and pharmaceutical compositions containing them - Google Patents

Benzopyrans and pharmaceutical compositions containing them

Info

Publication number
HK1014137A1
HK1014137A1 HK98113216A HK98113216A HK1014137A1 HK 1014137 A1 HK1014137 A1 HK 1014137A1 HK 98113216 A HK98113216 A HK 98113216A HK 98113216 A HK98113216 A HK 98113216A HK 1014137 A1 HK1014137 A1 HK 1014137A1
Authority
HK
Hong Kong
Prior art keywords
benzopyrans
pharmaceutical compositions
compositions containing
pharmaceutical
compositions
Prior art date
Application number
HK98113216A
Other languages
English (en)
Inventor
Paul W Manley
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10774940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1014137(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1014137A1 publication Critical patent/HK1014137A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK98113216A 1995-05-24 1998-12-11 Benzopyrans and pharmaceutical compositions containing them HK1014137A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9510477.4A GB9510477D0 (en) 1995-05-24 1995-05-24 Organic compounds
PCT/EP1996/002257 WO1996037490A1 (en) 1995-05-24 1996-05-24 Benzopyrans and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
HK1014137A1 true HK1014137A1 (en) 1999-09-24

Family

ID=10774940

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98113216A HK1014137A1 (en) 1995-05-24 1998-12-11 Benzopyrans and pharmaceutical compositions containing them

Country Status (31)

Country Link
US (1) US5905156A (xx)
EP (1) EP0828733B1 (xx)
JP (1) JPH11505820A (xx)
KR (1) KR100437981B1 (xx)
CN (1) CN1077888C (xx)
AR (1) AR004489A1 (xx)
AT (1) ATE205204T1 (xx)
AU (1) AU703276B2 (xx)
BR (1) BR9609048A (xx)
CA (1) CA2217821C (xx)
CO (1) CO4700520A1 (xx)
CZ (1) CZ294474B6 (xx)
DE (1) DE69615019T2 (xx)
DK (1) DK0828733T3 (xx)
ES (1) ES2163634T3 (xx)
FI (1) FI973992A (xx)
GB (1) GB9510477D0 (xx)
HK (1) HK1014137A1 (xx)
HU (1) HU222772B1 (xx)
IL (1) IL118382A (xx)
MY (1) MY114924A (xx)
NO (1) NO314846B1 (xx)
NZ (1) NZ309765A (xx)
PL (1) PL184144B1 (xx)
PT (1) PT828733E (xx)
RU (1) RU2160735C2 (xx)
SK (1) SK283215B6 (xx)
TR (1) TR199701417T1 (xx)
TW (1) TW421646B (xx)
WO (1) WO1996037490A1 (xx)
ZA (1) ZA964209B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
GB9822024D0 (en) * 1998-10-09 1998-12-02 Novartis Ag Organic compounds
GB9909792D0 (en) * 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
US6384244B2 (en) 2000-05-18 2002-05-07 Merck & Co., Inc. Process for preparing cis- aminochromanols
US7098340B2 (en) * 2003-05-14 2006-08-29 Warner Lambert Company Llc Benzyl sulfonamide derivatives
KR100704009B1 (ko) * 2005-08-30 2007-04-04 한국화학연구원 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(ｎ-메틸치환술폰아미도)메틸-2ｈ-1-벤조피란 유도체
MX2018003828A (es) 2015-09-28 2018-06-22 Genentech Inc Compuestos terapeuticos y sus metodos de uso.
CN106008288A (zh) * 2016-06-15 2016-10-12 西北农林科技大学 一种苯磺酰胺类化合物及其用途
EP3601273B1 (en) * 2017-03-24 2021-12-01 Genentech, Inc. 4-piperidin-n-(pyrimidin-4-yl)chroman-7-sulfonamide derivatives as sodium channel inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2030627A6 (es) * 1990-11-28 1992-11-01 Uriach & Cia Sa J Procedimiento para la obtencion de compuestos benzopiranicos.
KR950009863B1 (ko) * 1991-05-22 1995-08-29 재단법인한국화학연구소 벤조피란 유도체와 그의 제조방법
TW244350B (xx) * 1991-12-14 1995-04-01 Hoechst Ag
US5236935A (en) * 1992-05-21 1993-08-17 Korea Research Institute Of Chemical Technology Benzopyran derivatives and processes for the preparation thereof

Also Published As

Publication number Publication date
ES2163634T3 (es) 2002-02-01
GB9510477D0 (en) 1995-07-19
CZ368897A3 (cs) 1998-02-18
TW421646B (en) 2001-02-11
DK0828733T3 (da) 2001-12-17
IL118382A0 (en) 1996-09-12
CN1077888C (zh) 2002-01-16
DE69615019D1 (de) 2001-10-11
SK283215B6 (sk) 2003-03-04
TR199701417T1 (xx) 1998-02-21
CO4700520A1 (es) 1998-12-29
RU2160735C2 (ru) 2000-12-20
HUP9801751A2 (hu) 1999-06-28
CN1185153A (zh) 1998-06-17
WO1996037490A1 (en) 1996-11-28
FI973992A (fi) 1997-12-09
AR004489A1 (es) 1998-12-16
NZ309765A (en) 2000-01-28
CA2217821A1 (en) 1996-11-28
DE69615019T2 (de) 2002-06-06
KR100437981B1 (ko) 2004-07-16
AU6000896A (en) 1996-12-11
HU222772B1 (hu) 2003-10-28
NO975365L (no) 1998-01-15
MX9709004A (es) 1998-03-31
HUP9801751A3 (en) 1999-08-30
FI973992A0 (fi) 1997-10-17
MY114924A (en) 2003-02-28
CA2217821C (en) 2008-05-06
EP0828733A1 (en) 1998-03-18
IL118382A (en) 2000-01-31
PL324042A1 (en) 1998-05-11
ZA964209B (en) 1997-11-24
NO975365D0 (no) 1997-11-21
PL184144B1 (pl) 2002-09-30
KR19990021925A (ko) 1999-03-25
JPH11505820A (ja) 1999-05-25
ATE205204T1 (de) 2001-09-15
AU703276B2 (en) 1999-03-25
US5905156A (en) 1999-05-18
SK157797A3 (en) 1998-05-06
PT828733E (pt) 2002-02-28
NO314846B1 (no) 2003-06-02
BR9609048A (pt) 1999-02-23
EP0828733B1 (en) 2001-09-05
CZ294474B6 (cs) 2005-01-12

Similar Documents

Publication Publication Date Title
IL116851A (en) 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
IL119078A (en) Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them
ZA962399B (en) Taxoids their preparation and pharmaceutical compositions containing them
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL124994A0 (en) Taxoids preparation thereof and pharmaceutical compositions containing same
IL117860A0 (en) Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them
IL122293A0 (en) Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them
IL122717A0 (en) Compounds and pharmaceutical compositions containing them
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
ZA967827B (en) Pharmaceutical compositions
IL117878A (en) Taxoids their preparation and pharmaceutical compositions containing them
ZA967800B (en) Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
HUP9602196A2 (en) Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof
EG24294A (en) Pharmaceutical compositions
GB9506382D0 (en) Pharmaceutical compositions
ZA962633B (en) Taxoids their preparation and pharmaceutical compositions containing them
GB9513972D0 (en) Pharmaceutical compositions
IL118672A (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
HK1014137A1 (en) Benzopyrans and pharmaceutical compositions containing them
HUP9802291A3 (en) Penicillaminamide derivatives and pharmaceutical compositions containing them
IL117618A0 (en) Diphenylmethyl-azetidinone derivatives and pharmaceutical compositions containing the same
IL117634A0 (en) Taxoids their preparation and pharmaceutical compositions containing them
ZA9610740B (en) Taxoids their preparation and pharmaceutical compositions containing them
IL122191A0 (en) Pharmaceutical compositions containing substituted benzopyrans

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090524